Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment.

日本介入放射学学会和日本植入式端口辅助治疗学会提出的带有端口系统的肝动脉灌注化疗的临床实践指南。

• 影响指数: 12.43
• 发表时间: Sep 2022
• 来源期刊: Liver Cancer
• DOI: 10.1159/000524893
• PMID: 36158592
• 文章类型: Journal Article
• 作者列表: Ueshima K,Komemushi A,Aramaki T,Iwamoto H,Obi S,Sato Y,Tanaka T,Matsueda K,Moriguchi M,Saito H,Sone M,Yamagami T,Inaba Y,Kudo M,Arai Y

关键词: Hepatic arterial infusion chemotherapy; Hepatic arterial infusion chemotherapy with a port system; Hepatocellular carcinoma; Liver cancer; Liver metastases

Abstract

Hepatocellular carcinoma is one of the leading causes of cancer-related death both in Japan and globally. In the advanced stage, hepatic arterial infusion chemotherapy (HAIC) is one of the most commonly used treatment options for liver cancer in Japan, and implantation of a catheter system (called a port system) in the body is a treatment method that has evolved mainly in Japan. The Guideline Committee of the Japanese Society of Interventional Radiology and the Japanese Society of Implantable Port Assisted Treatment jointly published clinical practice guidelines for HAIC with a port system to ensure its appropriate and safe performance in Japanese in 2018. We have written an updated English version of the guidelines with the aim of making this treatment widely known to experts globally. In this article, the evidence, method, indication, treatment regimen, and maintenance of the system are summarized.

摘要

肝细胞癌是日本和全球癌症相关死亡的主要原因之一。在高级阶段，肝动脉灌注化疗（HAIC）是日本肝癌最常用的治疗选择之一，在体内植入导管系统（称为端口系统）是一种主要在日本发展的治疗方法。日本介入放射学学会指南委员会和日本植入式港口辅助治疗学会联合发布了HAIC的临床实践指南，该指南具有港口系统，以确保其在2018年在日本的适当和安全表现。我们编写了指南的最新英文版，目的是使全球专家广泛了解这种治疗方法。在这篇文章中,证据,方法，指示,治疗方案，并对系统的维护进行了总结。